We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Shining Light on Farm & Food Policy for 20 Years.
Wednesday, November 20, 2024
Bayer is another step closer to getting its wish — a date before the Supreme Court where it can argue that the Federal Insecticide, Fungicide, and Rodenticide Act pre-empts state laws that have allowed plaintiffs who claim Roundup caused their cancer to prevail in court cases against the agrochemical company.
A Georgia man who used Roundup for decades won his case against Monsanto Monday when a federal appeals court found that the Federal Insecticide, Fungicide, and Rodenticide Act did not preempt his state tort law claims that the company failed to warn him of the dangers of using the product.
The Center for Food Safety, Beyond Pesticides and several farmworker advocacy groups are pushing the EPA to cancel glyphosate's registration in light of a federal court decision that found fault with the agency's human health assessment.
Bayer said it will appeal a jury verdict from a local court in Philadelphia awarding $175 million, including $150 million in punitive damages,to an 83-year-old city resident who claimed exposure to Roundup caused his cancer.
Bayer is hailing a decision by the 11th Circuit Court of Appeals to reconsider its judgment in a case involving the question of whether federal pesticide law trumps state failure-to-warn claims.
The Supreme Court has rejected Monsanto’s second petition seeking review of a decision that found the nation’s pesticide law does not pre-empt state-law claims that Roundup was misbranded because it did not carry a cancer warning.
